Section Review: Anti-infectives: Novel herpes treatments: A review
- 1 February 1996
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 5 (2) , 169-183
- https://doi.org/10.1517/13543784.5.2.169
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDSAIDS, 1995
- Oral brivudin versus intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trialAntiviral Research, 1995
- Valtrex* (Valaciclovir, VACV) for the treatment of recurrent genital herpes: S. Safrin, San Francisco General Hospital, California, USA for the International Valaciclovir HSV Study GroupAntiviral Research, 1995
- n-docosanol prevents vaginal transmission of SIVmac251 in rhesus macaquesAntiviral Research, 1995
- Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDSAntiviral Research, 1991
- FoscarnetDrugs, 1991
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-β-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: Comparison with (E)-5-(2-bromovinyl)-2′-deoxyuridine (BrVUdR)Antiviral Research, 1988
- Ganciclovir for Treatment of Renal Transplant-Associated Primary Cytomegalovirus PneumoniaThe Journal of Infectious Diseases, 1988
- In vitro and in vivo antiviral activity of 1-β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compoundsAntiviral Research, 1984